Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?;¿Es un error médico no investigar en los pacientes cirróticos la presencia de encefalopatía hepática mínima?

Revista Espanola de Enfermedades Digestivas

Volumn 94, Issue 9, 2002, Pages 551-557

  Querro Guillen J C ^a   Groeneweg, M ^a   Jimenez Saenz M ^a   Schalm, S W ^a   Herrerias Gutierrez J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Clinical significance; Diagnosis; Hepatic encephalopathy; Subclinical latent; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BRANCHED CHAIN AMINO ACID; DISACCHARIDE; LACTITOL; LACTULOSE;

ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HUMAN; IATROGENIC DISEASE; LIVER CIRRHOSIS; NEUROLOGIC DISEASE; PROGNOSIS; QUALITY OF LIFE; SCREENING; SIDE EFFECT; ELECTROPHYSIOLOGY; MEDICAL ERROR; PATHOPHYSIOLOGY; PSYCHOMETRY; REVIEW;

ELECTROPHYSIOLOGY; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MEDICAL ERRORS; PROGNOSIS; PSYCHOMETRICS;

EID: 0042470872     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957; 2: 867-71.
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - Definition, nomenclature, diagnosis and quantification: Final report of the working party of the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
3. Zeegen R, Drinkwater JE, Dawson AM. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 1970; 2: 633-6.
4. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75: 462-9.
5. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis 1996; 16: 241-8.
6. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Döll W, Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26: 622-30.
7. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt hepatic encephalopathy. Arch Intern Med 1980; 140: 519-21.
8. Tarter RE, Hegedus AM, van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984; 86: 1421-7.
9. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, nonshunted patients with cirrhosis. J Hepatol 1986; 3: 75-82.
10. Marchesini G, Zoli M, Dondi C, Cecchini L, Angiolini A, Bianchi FB, Pisi E. Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid balance. Dig Dis Sci 1980; 25: 763-8.
11. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.
12. McCrae M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53: 758-63.
13. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22: 541-50.
14. Levy LJ, Bolton RP, Losowsky MS. The use of the visual evoked potential (VEP) in delineating a state of subclinical encephalopathy. A comparison with the number connection test (NCT). J Hepatol 1987; 5: 211-17.
15. Zeneroli ML, Cioni G, Ventura P, Russo AM, Venturini I, Casalgrandi G, et al. Interindividual variability of the number connection test. J Hepatol 1992; 15: 263-4.
16. Quero JC, Hartman IJC, Meulstee J, Hop WCJ, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24: 556-60.
17. Yang SS, Wu CH, Chiang TR, Chen DS. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology 1998; 27: 357-61.
18. De Bruijn KM, Blendis LM, Zilm DH, Carlen PL, Anderson GH. Effect of dietary protein manipulations in subclinical portal-systemic encephalopathy. Gut 1983; 24: 53-60.
19. Egberts EH, Schomerus H, Hamster W, Jürgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. Gastroenterology 1985; 88: 887-95.
20. Schomerus H, Weissenborn K, Hamster W, Ruckert N, Hecker H. The PSE-Syndrom-Test. Swets Test Services. Frankfurt: Swets & Zeitlinger, 1999.
21. Zeneroli ML, Pinelli G, Gollini G, Penne A, Messori E, Zani G, et al. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Gut 1984; 25: 291-9.
22. Mehndirrata MM, Sood GK, Sarin SK, Gupta M. Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol 1990; 85: 799-803.
23. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterol 1990; 37: 332-4.
24. Kugler CF, Lotterer E, Petter J, Wensing G, Taghavy A, Hahn EG, et al. Visual event-related P300 potentials in early portosystemic encephalopathy. Gastroenterology 1992; 103: 302-10.
25. Kullman F, Hollerbach S, Holstege A, Scholmerich J. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 1995; 22: 101-10.
26. Amodio P, Quero JC, Del Piccolo F, Gatta A, Schalm SW. Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric with spectral-EEG. Metab Brain Dis 1996; 11: 315-27.
27. Amodio P, Marchetti P, Del Piccolo F, de Tottchaninoff M, Varghese P, Zuliani C, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110: 1334-44.
28. Sandford SL, Tarter RE, Sclabassi R, Van Thiel DH. Sensory information processing in patients with nonalcoholic cirrhosis. Short-latency visual, auditory, and somatosensory event-related potentials. J Neurol Sci 1987; 80; 269-76.
29. Johansson U, Anderson T, Persson A, Eriksson LS. Visual evoked potential - a tool in the diagnosis of hepatic encephalopathy? J Hepatol 1989; 9: 227-33.
30. Davies MG, Rowan MJ, Feely J. Flash visual evoked responses in the early encephalopathy of chronic liver disease. Scand J Gastroenterol 1990; 25: 1205-14.
31. Davies MG, Rowan MJ, Macmathuna P, Keeling PWN. Weir DG, Feely J. The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease. Hepatology 1990; 12: 688-94.
32. Giger-Mateeva VI, Riemslag FC, Reits D, Liberov B, Jones EA, Spekreije H. Visual event-related potentials in cirrhotic patients without overt encephalopathy. Metab Brain Dis 2000; 15: 179-91.
33. Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001; 35: 37-45.
34. Van Der Rijt CCD, Schalm SW, de Groot GH, de Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroenceph Clin Neurophysiol 1984; 57: 423-6.
35. Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Künkel H. Neurophysiological assessment of early hepatic encephalopathy. Electroenceph Clin Neurophysiol 1990; 75: 289-95.
36. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994; 21: 1023-8.
37. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJC, Essink-Bot ML, Hop WCJ, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
38. Groeneweg M, Moerland W, Quero JC, Hop WCJ, Krabbbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000; 32: 748-53.
39. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001, 16: 37-41.
40. Hartman IJC, Groeneweg M, Quero JC, Beijeman SD, de Man RA, Hop WCJ, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-34.
41. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
42. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric test. Hepatology 1999; 29: 1662-7.
43. McClain CJ, Potter TJ, Kromhout JP, Zieve L. The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy. J Hepatol 1994; 21: 1092-6.
44. Morgan MY, Alonso M, Stanger LC. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cros-over study. J Hepatol 1989; 8: 208-17.
45. Salerno F, Moser P, Maggi A, Vitaliani G, Benetti G. Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy. J Hepatol 1994; 21: 1092-6.
46. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26: 1410-4.
47. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000; 8: 1549-52.
48. Quero JC, Groeneweg M, Meulstee J, Hop WCJ, Schalm SW. Does a low-dose of lactulose improve quality of life in patients with liver cirrhosis? In: Record CO, ed. Advances in hepatic encephalopathy and metabolism in liver disease. Boca Raton: CRC press, 1997. p. 459-65.
49. Plauth M, Egberts EH, Hamster W, Török M, Müller PH, Brand O, et al. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol 1993; 17: 308-14.
50. O'Neil D. Physicians, elderly drivers and dementia. Lancet 1992; 339: 41-3.
51. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. The selection of diagnostic tests. In: Clinical epidemiology, a basic science for clinical medicine. Little, Brown and Company, USA, 1991.
52. Lockwood AH. "What's in a name?" Improving the care of cirrhotics. J Hepatol 2000; 32: 859-61.